Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.

International journal of clinical oncology - 1 Jun 2020

Sonoda Yukihiko

Abstract excerpt

The publication of the 2016 World Health Organization Classification of Tumors of the Central Nervous System (2016 WHO CNS) represented a major change in the classification of brain tumors. It is essential to determine the IDH and 1p/19q statuses of diffuse gliomas to ensure that the final diagnosis is accurate. The integrated diagnostic method outlined in the 2016 WHO CNS has enabled more precise prediction of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Prognosis

Share to Risk Factors

Share to World Health Organization

Source

Identifiers

PMID: 32020379
DOI: 10.1007/s10147-020-01628-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.PMID 32020379Read ↗

Adult type diffuse gliomas in the new 2021 WHO Classification.Semantic proximity Read ↗

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.Semantic proximity Read ↗

Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.Semantic proximity Read ↗

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse GliomasSemantic proximity Read ↗

[Update on the 2016 WHO classification of tumors of the central nervous system - Part 1: Diffusely infiltrating gliomas].Semantic proximity Read ↗

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsSemantic proximity Read ↗

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomasSemantic proximity Read ↗

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.Semantic proximity Read ↗

Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.Semantic proximity Read ↗

The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.Semantic proximity Read ↗

Moving toward molecular classification of diffuse gliomas in adultsSemantic proximity Read ↗

Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.